5 Undervalued Stocks for a Sideways Market
Plus, updates on the debt ceiling and commercial real estate.
David Sekera
Dave Sekera, CFA, is chief U.S. market strategist for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. Before assuming his current role in August 2020, he was a managing director for DBRS Morningstar. Additionally, he regularly published commentary to provide investors with relevant insights into the corporate-bond markets.
Prior to joining Morningstar in 2010, Sekera worked in the alternative asset-management field and has held positions as both a buy-side and sell-side analyst. He has over 25 years of analytical experience covering the securities markets.
Sekera holds a bachelor's degree in finance and decision sciences from Miami University. He also holds the Chartered Financial Analyst® designation. Follow David on Twitter: @MstarMarkets. Please note, Dave does not use either WhatsApp or Telegram. Anyone claiming to be Dave on these apps is an impersonator. He will not contact anyone on these apps and will not provide any content or advice on either app.
Latest
2 Undervalued Medtech Stocks: Opportunities in Liquid Biopsy
Liquid biopsies could usher in a paradigm shift in cancer detection and grow exponentially.
May 19, 2023
Despite Rally, Stock Market Remains Undervalued
Our monthly outlook includes sector valuations, a look at commercial real estate, and the latest on banks.
May 8, 2023
4 More Undervalued Stocks to Buy After Earnings
Plus, what the Federal Reserve meeting may mean for markets this week.
May 1, 2023
5 Undervalued Stocks to Buy After Earnings
Plus, what impact earnings reports from mega-cap stocks may have on the markets this week.
Apr 24, 2023
The 5 Most Expensive Stocks to Avoid Now
Plus, our bond market outlook and key takeaways from bank earnings so far.
Apr 17, 2023
Should You Invest in Growth Stocks or Value Stocks Now?
Plus, what to watch for in bank earnings and stock picks for the week.
Apr 10, 2023
4 Undervalued Growth Stocks for 2Q 2023
Plus, our stock market outlook for the new quarter.
Apr 3, 2023
Second-Quarter 2023 Stock Market Outlook: Undervalued, but a Rough Road Ahead
Monetary tightening is either at, or close to, an end, but market will be looking for increase in leading economic indicators to begin viable rally.
Mar 31, 2023
How to Invest in 2023’s Uncertain Market
This strategy can limit downside risk and boost investor confidence.
Mar 27, 2023
4 Undervalued Financial Stocks for the Long-Term Market
Plus, the latest on the banking crisis and what the Fed might do next.
Mar 20, 2023
Investment Impact of Banking Crisis
Don’t panic: This isn’t 2008. In fact, it’s an opportunity to find undervalued stocks unfairly pulled down with bank carnage. Here’s what to do now.
Mar 17, 2023
4 Undervalued Small-Value Stocks to Buy
Plus, bank liquidity and what to expect in the markets this week.
Mar 13, 2023
The U.S. Stock Market Is Undervalued, but It Looks Like a Rough Road Ahead
Key takeaways from our March 2023 outlook.
Mar 3, 2023
Long-Term Stocks to Buy: Cyclicals That Aren’t Really Cyclical
Plus, an earnings season recap and why specialty chemicals stocks look cheap today.
Feb 27, 2023
6 Cheap Stocks to Play Long-Term Growth Trends
Specialty chemicals companies stand to benefit from these structural growth themes.
Feb 24, 2023